Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 1,363

Document Document Title
WO/1993/005028A1
Crown ether compounds which can function as receptor molecules for species such as alcohols, especially for ethanol, and other materials capable of forming hydrogen bonds. The compounds are based on 1,7-diaza-12-crown-4 group, substitute...  
WO/1993/004142A1
Decomposable complex ligands may be stabilized by derivating them with blocking secondary or tertiary carbonic or sulfonic acids. Orientation layers and liquid crystal mixtures may be added to these stabilized derivates that cause in FLC...  
WO/1992/020682A1
Substituted anilides of formula (I), wherein Q is one of (Q-1), (Q-2) and (Q-3), and R?1� to R?5�, Y, Z and Z?1� are as defined in the text, arthropodicidal compositions containing such compounds; and a method for controlling arthr...  
WO/1992/013847A1
The present invention relates to hitherto unknown 3-substituted 1,2,3,4-oxatriazole-5-imine compounds which have proved to have biological effects making them suitable for treatment of cardiovascular diseases (blood clots), angina pector...  
WO/1992/011249A1
Arthropodicidal carboxanilides of formulae (I) and (II) wherein Q, X, X?1¿, Y and G are as defined in the text, arthropodicidal compositions containing said compounds and a method for using the compounds to control arthropods.  
WO1991012243A3  
WO/1991/012243A2
A monomer and polymers resulting therefrom, the monomer comprising (I), wherein n = 1 or 2; m = 1 or 2; R' = H or CH3; X = -O-, -CH2, -NR-; R = H, -alkyl, -aryl, -CH2(CH2)y-C = N, -CH2O alkyl, -(CH2)yOH, -CH2CH(OH)CH3 wherein y = 1 - 12;...  
WO/1991/010655A1
The invention relates to partially novel metal complexes, salts and double salts of 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane compounds of formula (I), wherein Q1 and Q2 mean hydrogen or a group of formula (III), in the groups of form...  
WO/1991/009863A1
Organophosphorus-substituted oxadiazines (I) are disclosed which exhibit insecticidal, acaricidal and nematicidal activity, as well as compositions including such compounds, and methods for controlling insects, acarids or nematodes emplo...  
WO/1990/014343A1
Pharmaceutical composition for decorporating radioactive isotopes from living organisms comprising as active agent a product prepared by reacting 1,4,10,17-tetraoxa-7,16-diazacyclooctadecane with 2-bromomalonic acid disodium salt.  
WO1990007111A3  
WO/1990/007111A2
A molecular model of the interaction of various non beta-lactam antibiotics with the active site of a penicillin receptor has been developed so that it is now possible to predict the ''fit'' and ''reactivity'' of potential antibacterial ...  
WO/1990/003975A1
A process is provided for the preparation of Mn(II) chelates for use as contrast agents in magnetic resonance imaging, said process comprising reacting insoluble manganese (II) oxide with an aqueous suspension comprising a molar equivale...  
WO/1989/010752A1
A retroviral protease inhibiting compound of formula (I) or a pharmaceutically acceptable salt, prodrug or ester thereof.  
WO/1989/000557A1
There are provided chelating agents particularly useful for the preparations of diagnostic and therapeutic agents for magnetic resonance imaging, scintigraphy, ultrasound imaging, radiotherapy and heavy metal detoxification, said agents ...  
WO/1987/005030A1
A conjugate compound has the structure (I), wherein R1 is -(CH2)p-R6-(CH2)q- where p and q are the same or different and are 0, 1 or 2, and -R6- is -(CH2)n-, where n is 0 or 1, -NH-, -O-, -S- or (II), R1 optionally being alkyl substitute...  
WO/1985/003078A1
Platinum and crown ether complexes having the general formula (I), wherein C is a mono- or bicyclic crown ether, A is ammonia or a mono- or di-Cl-C4-alkylamine or an amine function contained in the crown ether and X is halogen or the ani...  
WO/1982/004252A1
N-hydroxyethylated macrocyclic polyamines of the formula (FORMULA) in which X is O or N(CH2CH2OH), and each of Y1 and Y2, which are equal or different, are (FORMULA) with the proviso that X is different from N (CH2CH2OH) when both Y1 and...  
WO/1982/004253A1
New aza-crown-ethers having the general formula (FORMULA) in which a) X is oxygen and R is hydrogen, alkyl, aralkyl, aryl, alkoxyalkyl, hydroxyalkyl, alkoxycarbonylalkyl, carbamoylalkyl, nitrophenyldiazophenyl or (FORMULA) in which n is ...  
WO/1981/002420A1
Betaine is recovered from natural sources such as beet molasses, rest molasses and vinasse by diluting the molasses to 25-50% solids, introducing the molasses to the top of a chromatographic column containing a salt of polystyrene sulfon...  
JP2020530452A
To provide a compound useful as an immunomodulator. A compound having the formula (I) or (II) (including its stereoisomer and a pharmaceutically acceptable salt): [Chemical Formula 1].(In the formula, R, R1, R2a, R2b, R2c, R3, R4, R5, R6...  
JP2020529439A
The present invention describes the dihydrooxydiajinone compound of the general formula (I): (In the formula, R1, R2, R3And R4As defined herein), methods of preparing compounds, intermediate compounds useful for preparing compounds, phar...  
JP2020128379A
[Subject] The therapeutic method of diseases, such as ischemia, heart failure, a neurodegenerating disease, and a hereditary obstacle that risks a creatine kinase system, is provided. [Means for Solution] A therapeutic method including p...  
JP6746802B2  
JP6746614B2  
JP2020520998A
The macrocyclic compound and compound which have two or more large annular machines, and the iron coordinated complex which has a macrocyclic compound and two large annular machines or more at least for Iron distribution are provided. Ir...  
JP2020516611A
The technology of the present invention includes glioma, breast cancer, adrenal cortex cancer, cervical carcinoma, vulvar carcinoma, endometrial carcinoma, primary ovarian carcinoma, metastatic ovarian carcinoma, non-small cell lung canc...  
JP2020515585A
The object of the present invention is to use a new catalyst system, to be racemate or to provide a new and advantageous method for the rate of one mirror image isomer to prepare high indoxacarb commercially focusing on a chiral from an ...  
JP6636031B2  
JP2020500186A
making N metastatic oxidizer react to the quality of a thioether group in the redox reaction in water environment, and making conjugate output form -- chemicals -- alternative conjugate is attained through redox reaction nature. In an em...  
JP6586416B2  
JP6581559B2  
JP6475301B2  
JP6464970B2  
JP6461113B2  
JP2018531894A
The present invention is the method of denaturing isocyanate which makes at least one sort of organic isocyanate which has more than one NCO functional value oligomer-ize under at least one sort of existence of a catalyst, A catalyst con...  
JP2018521972A
The present invention provides the Urea compound which has Formyl peptide receptor Mr. 1 (it may translate into FPRL1 hereafter) agonistic effect or its salt permitted pharmacologically, the medical-supplies constituent containing it, an...  
JP2018517762A
The present invention relates to antibody - or a peptide drug thing conjugate compound in which a covalent bond is carried out by disintegration linker which one or more crypto Ficin derivatives (large annular Depsi peptide) combine with...  
JP2018517696A
It is the process of preparing (E) - (5, 6-dihydro1, 4, 2-dioxazine 3- Il ) (2-hydroxyphenyl) meta-non O-methyl oxime, and is under existence of (i) metal Alkoxide , At least one nitrite salt chosen from nitrous acid n-butyl and nitrous ...  
JP2018513118A
In order that the present invention may check the cyclic compound shown by formula (I), and programmed-cell-death 1 (PD-1) signal channels of communication, And/or, it is related with the use of the compound for the disposal of the obsta...  
JP2018502911A
The medicine constituent in which the present invention contains a membrane permeability creatine prodrug and a membrane permeability creatine prodrug, And the therapeutic method of diseases, such as ischemia, heart failure and a neurode...  
JP2016536372A5  
JP6177768B2  
JP6174600B2  
JP6148006B2  
JP6111276B2  
JP2017052729A
To provide a method for manufacturing an oxaziridine compound used for various reactions as a variety of uses, such as oxidant, which is safe and simple and is capable of efficiently manufacturing while eliminating contamination of impur...  
JP2017031058A
To provide a novel cyclic depsipeptide derivative and a pest control agent comprising the same.The present invention provides a cyclic depsipeptide derivative represented by formula (1) or a stereoisomer thereof, and a pest control agent...  
JPWO2014119636A1
Medicine containing a new molecular entity and it which have an antiviral action, especially HIV duplicate prevention activity, especially an anti-HIV drug are provided. Conversion into 1a formula -- inside -- a ring -- A -- substitution...  
JP6068505B2  

Matches 401 - 450 out of 1,363